Showing results (31-40 of 73) with videos related to

Sort By:
Pageof 8
Cells|April 9, 2020
IL7-IL12 Engineered Mesenchymal Stem Cells (MSCs) Improve A CAR T Cell Attack Against Colorectal Cancer CellsAndreas A Hombach, Ulf Geumann, Christine Günther, et al.
Clinical & Developmental Immunology|April 7, 2012
Improved activation toward primary colorectal cancer cells by antigen-specific targeting autologous cytokine-induced killer cellsClaudia Schlimper, Andreas A Hombach, Hinrich Abken, et al.
Human Gene Therapy|December 7, 2017
CD20-CD19 Bispecific CAR T Cells for the Treatment of B-Cell MalignanciesAlexandra Martyniszyn, Ann-Christin Krahl, Maya C André, et al.
Blood|August 19, 2016
Chimeric antigen receptor T cells targeting Fc μ receptor selectively eliminate CLL cells while sparing healthy B cellsElena Faitschuk, Andreas A Hombach, Lukas P Frenzel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2007
T cell activation by antibody-like immunoreceptors: the position of the binding epitope within the target molecule determines the efficiency of activation of redirected T cellsAndreas A Hombach, Verena Schildgen, Claudia Heuser, et al.
Scandinavian Journal of Immunology|November 20, 1998
Generation of the single chain antibody fragment conserves the idiotypic profile of the anti-CD30 monoclonal antibody HRS3A Hombach, C Pohl, C Heuser, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 7, 2001
CD4+ T cells engrafted with a recombinant immunoreceptor efficiently lyse target cells in a MHC antigen- and Fas-independent fashionA Hombach, C Heuser, T Marquardt, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 26, 1999
Characterization of a chimeric T-cell receptor with specificity for the Hodgkin's lymphoma-associated CD30 antigenA Hombach, C Heuser, R Sircar, et al.
Pageof 8